Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyses of a Randomized Trial (AIM Study)
Bråten, Lars Christian Haugli; Gjefsen, Elisabeth; Gervin, Kristina; Pripp, Are Hugo; Skouen, Jan Sture; Schistad, Elina Iordanova; Pedersen, Linda Margareth; Wigemyr, Monica; Selmer, Kaja Kristine; Dalsbotten Aass, Hans Christian; Goll, Guro Løvik; Brox, Jens Ivar; Espeland, Ansgar; Grøvle, Lars; Zwart, John Anker Henrik; Storheim, Kjersti
Peer reviewed, Journal article
Published version
Permanent lenke
https://hdl.handle.net/11250/3098546Utgivelsesdato
2023Metadata
Vis full innførselSamlinger
Sammendrag
Objective: Randomized trials testing the effect of antibiotics for chronic low back pain (LBP) with vertebral bone marrow changes on
MRI (Modic changes) report inconsistent results. A proposed explanation is subgroups with low grade discitis where antibiotics are
effective, but there is currently no method to identify such subgroups. The objective of the present study was to evaluate whether
distinct patterns of serum cytokine levels predict any treatment effect of oral amoxicillin at one-year follow-up in patients with chronic
low back pain and Modic changes at the level of a previous lumbar disc herniation.
Design: We used data from an overpowered, randomized, placebo-controlled trial (the AIM study) that tested 100 days of oral 750 mg
amoxicillin vs placebo three times daily in hospital outpatients with chronic (>6 months) LBP with pain intensity ≥5 on a 0–10
numerical rating scale and Modic changes type 1 (oedema type) or 2 (fatty type). We measured serum levels of 40 inflammatory
cytokines at baseline and analysed six predefined potential predictors of treatment effect based on cytokine patterns in 78 randomized
patients; three analyses with recursive partitioning, one based on cluster analysis and two based on principal component analyses. The
primary outcome was the Roland–Morris Disability Questionnaire score at one-year follow-up in the intention to treat population. The
methodology and overall results of the AIM study were published previously.
Results: The 78 patients were 25–62 years old and 47 (60%) were women. None of the three recursive partitioning analyses resulted
in any suggested subgroups. Of all main analyses, the largest effect estimate (mean difference between antibiotic and placebo groups)
was seen in a subgroup not predefined as of main interest (Cluster category 3+4; −2.0, 95% CI: −5.2–1.3, RMDQ points; p-value for
interaction 0.54).
Conclusion: Patterns of inflammatory serum cytokine levels did not predict treatment effect of amoxicillin in patients with chronic
LBP and Modic changes.